United States · FDA National Drug Code directory

brivaracetam

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72205-270_e87caa94-1064-4a45-91e8-0219eb1d2d39
Product NDC
72205-270
Form
TABLET, FILM COATED
Composition / generic term
brivaracetam
Labeler
Novadoz Pharmaceuticals LLC
Marketing category
ANDA
Marketing start / end (source format)
20251113
Source listing expiry
20271231

Source-listed ingredients

  • BRIVARACETAM — 75 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 60 TABLET, FILM COATED in 1 BOTTLE (72205-270-60) · 72205-270-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →